Back to Search Start Over

KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.

Authors :
Decroos A
Cheminant M
Bruneau J
Carras S
Parinet V
Pelletier L
Lacroix L
Martin N
Giustiniani J
Lhermitte L
Asnafi V
Battistella M
Lemonnier F
De Leval L
Sicard H
Bonnafous C
Gauthier L
Genestier L
Caruso S
Gaulard P
Hermine O
Ortonne N
Source :
Haematologica [Haematologica] 2023 Oct 01; Vol. 108 (10), pp. 2830-2836. Date of Electronic Publication: 2023 Oct 01.
Publication Year :
2023

Subjects

Subjects :
Humans
Receptors, KIR3DL2
Lymphoma, T-Cell, Peripheral drug therapy
Lymphoma, T-Cell, Peripheral genetics
Lymphoma, T-Cell, Cutaneous
Skin Neoplasms drug therapy

Details

Language :
English
ISSN :
1592-8721
Volume :
108
Issue :
10
Database :
MEDLINE
Journal :
Haematologica
Publication Type :
Editorial & Opinion
Accession number :
37165836
Full Text :
https://doi.org/10.3324/haematol.2022.282220
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details